Exploratory data analysis on the effects of non pharmacological treatment for knee osteoarthritis

Clinical and Experimental Rheumatology

Volumn 28, Issue 2, 2010, Pages 250-253

  Ceccarelli, Fulvia ^a   Perricone, Carlo ^a   Alessandri, Cristiano ^a   Modesti, Mariagrazia ^a   Iagnocco, Annamaria ^a   Croia, Cristina ^a   Di Franco, Manuela ^a   Valesini, Guido ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cytokines; Osteoarthritis; Spa therapy; Ultrasonography

Indexed keywords

CARTILAGE OLIGOMERIC MATRIX PROTEIN; CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GROWTH FACTOR;

ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; PAIN ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SPA TREATMENT; TREATMENT DURATION; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

BATHS; COHORT STUDIES; CYTOKINES; EXTRACELLULAR MATRIX PROTEINS; GLYCOPROTEINS; HEALTH RESORTS; HUMANS; MUD THERAPY; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT;

EID: 77952763363     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. PEAT G, MCCARNEY R, CROFT P: Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care. Ann Rheum Dis 2001; 60: 91-97
2. KWAN TAT S, PELLETIER JP, LAJEUNESSE D, FAHMI H, LAVIGNE M, MARTEL-PELLETIER J: The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells. Clin Exp Rheumatol 2008; 26: 295-304.
3. GOLDRING MB, OTERO M, TSUCHIMOCHI K, IJIRI K, LI Y: Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism. Ann Rheum Dis 2008; 67: 75-82.
4. FURUZAWA-CARBALLEDA J, MACIP-RODRÍGUEZ PM, CABRAL AR: Osteoarthritis and rheumatoid arthritis pannus have similar qualitative metabolic characteristics and proin flammatory cytokine response. Clin Exp Rheumatol 2008; 26: 554-560
5. CONROZIER T, POOLE AR, FERRAND F et al.: Serum concentrations of type II collagen biomarkers (C2C, C1, 2C and CPII) suggest different pathophysiologies in patients with hip osteoarthritis. Clin Exp Rheumatol 2008; 26: 430-435
6. BELLOMETTI S, CECCHETTIN M, GALZIGNA L: Mud pack therapy in osteoarthrosis. Changes in serum levels of chondrocyte markers. Clin Chim Acta 1997; 268: 101-106
7. CONROZIER T, MARRE JP, PAYEN-CHAMPENOIS C, VIGNON E: National survey on the non-pharmacological modalities prescribed by French general practitioners in the treatment of lower limb (knee and hip) osteoarthritis. Adherence to the EULAR recommendations and factors influencing adherence. Clin Exp Rheumatol 2008; 26: 793-798
8. FORESTIER R, DESFOUR H, TESSIER JM et al.: Spa-therapy in the treatment of knee osteoarthritis, a large randomised multicentre trial. Ann Rheum Dis 2009; 69: 60-65
9. ALTMAN R, ASCH E, BLOCH D et al.: Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986; 29: 1039-1049
10. LEQUESNE MG, MERY C, SAMSON M, GERARD P: Indexes of severity for osteoarthritis of the hip and knee. Validation - value in comparison with other assessment tests. Scand J Rheumatol Suppl 1987; 65: 85-89
11. BACKHAUS M, BURMESTER GR, GERBER T et al.: Working Group for Musculoskeletal Ultrasound in the EULAR Standing Committee on International Clinical Studies including Therapeutic Trials. Guidelines for musculoskeletal ultrasound in rheumatology. Ann Rheum Dis 2001; 60: 641-649
12. WAKEFIELD RJ, BALINT PV, SZKUDLAREK M et al.: OMERACT 7 Special Interest Group. Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol 2005; 32: 2485-2487
13. CECCARELLI F, PRIORI R, IAGNOCCO A et al.: Knee joint synovitis in Behçet's disease: a sonographic study. Clin Exp Rheumatol 2007; 25 (Suppl. 53): S76-79.
14. MEENAGH G, FILIPPUCCI E, DELLE SEDIE A et al.: Ultrasound imaging for the rheumatologist. XVIII. Ultrasound measurements. Clin Exp Rheumatol 2008; 26: 982-985
15. NAREDO E, CABERO F, PALOP MJ, COLLADO P, CRUZ A, CRESPO M: Ultrasonographic findings in knee osteoarthritis: A comparative study with clinical and radiographic assessment. Osteoarthritis Cartilage 2005; 13: 568-574
16. WOLLHEIM FA: A pain in the knee - is it osteoarthritis? Clin Exp Rheumatol 2008; 26: 227-229
17. D'AGOSTINO MA, CONAGHAN P, LE BARS M et al.: EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 1: Prevalence of inflammation in osteoarthritis. Ann Rheum Dis 2005; 64: 1703-1709
18. ZHANG W, DOHERTY M, PEAT G et al.: EULAR evidence based recommendations for the diagnosis of knee osteoarthritis. Ann Rheum Dis [Epub Sep 17 2009].
19. LEE EY, LEE ZH, SONG YW: CXCL10 and autoimmune diseases. Autoimmun Rev 2009; 8: 379-383
20. HANAOKA R, KASAMA T, MURAMATSU M et al.: A novel mechanism for the regulation of IFN-gamma inducible protein-10 expression in rheumatoid arthritis. Arthritis Res Ther 2003; 5: 74-81.
21. DRAGOMIR AD, KRAUS VB, RENNER JB et al.: Serum cartilage oligomeric matrix protein and clinical signs and symptoms of potential pre-radiographic hip and knee pathology. Osteoarthritis Cartilage 2002; 10: 687-691